The law firms of Bernstein Litowitz Berger & Grossmann LLP and Grant & Eisenhofer P.A. announce pendency of class action in In re Merck & Co., Inc. Vytorin / Zetia Securities Litigation

NEW YORK, Jan. 25, 2013 /PRNewswire/ --

UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF NEW JERSEY

 

IN RE MERCK & CO., INC. VYTORIN / ZETIA
SECURITIES LITIGATION

 

Civil Action No. 08-2177 (DMC) (JAD)

 

SUMMARY NOTICE OF PENDENCY OF CLASS ACTION

To: All persons and entities that purchased or acquired Merck & Co., Inc. ("Merck") common stock, or call options, and/or sold Merck put options, during the period between December 6, 2006 through and including March 28, 2008, and who did not sell their stock and/or options on or before January 14, 2008, and who were damaged thereby (the "Class").

YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the District of New Jersey, that the above-captioned action (the "Action") has been certified as a class action.

IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS WILL BE AFFECTED BY THIS ACTION. A full printed Notice of Pendency of Class Action is currently being mailed to known Class Members. If you have not yet received a full printed Notice, you may obtain copies of this document by downloading it from www.merckvytorinsecuritieslitigation.com or by contacting the Notice Administrator:

In re Merck & Co., Inc. Vytorin / Zetia Securities Litigation
P.O. Box 4178
Portland, OR 97208-4178
(877) 866-5915

If you did not receive the Notice by mail, and you are and decide to remain a member of the Class, please send your name and address to the Notice Administrator so that if any further notices are disseminated in connection with the Action, you will receive them.

Inquiries, other than requests for the Notice, may be made to Class Counsel:

Salvatore J. Graziano

Jay W. Eisenhofer

BERNSTEIN LITOWITZ BERGER  

Daniel L. Berger

& GROSSMANN LLP 

GRANT & EISENHOFER P.A.

1285 Avenue of the Americas 

485 Lexington Avenue

New York, NY 10019  

New York, NY 10017

(800) 380-8496 

(646) 722-8500

If you are a Class Member, you have the right to decide whether to remain a member of the Class. If you choose to remain a member of the Class, you do not need to do anything at this time other than to retain your documentation reflecting your transactions and holdings in Merck common stock and options during the period from December 6, 2006 through and including March 28, 2008. You will automatically be included in the Class. If you are a Class Member and do not exclude yourself from the Class, you will be bound by the proceedings in the Action, including all past, present and future orders and judgments of the Court, whether favorable or unfavorable.

If you ask to be excluded from the Class, you will not be bound by any judgment in the Action, and you will not be eligible to receive a share of any money which might be recovered for the benefit of the Class. To exclude yourself from the Class, you must submit a written request for exclusion postmarked no later than March 1, 2013 in accordance with the instructions set forth in the full printed Notice. Pursuant to Rule 23(e)(4) of the Federal Rules of Civil Procedure, it is within the Court's discretion whether to allow a second opportunity to request exclusion from the Class if there is a settlement or judgment in the Action. The trial in the Action has been scheduled by the Court to begin on March 4, 2013.

Further information may be obtained by directing your inquiry in writing to the Notice Administrator.

BY ORDER OF THE COURT
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF NEW JERSEY

SOURCE United States District Court for the District of New Jersey




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.